nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—CYP2D6—Parkinson's disease	0.861	1	CbGaD
Oxprenolol—Penbutolol—HTR1A—Parkinson's disease	0.00132	0.131	CrCbGaD
Oxprenolol—Alprenolol—HTR1A—Parkinson's disease	0.00111	0.109	CrCbGaD
Oxprenolol—Pindolol—HTR1A—Parkinson's disease	0.000955	0.0941	CrCbGaD
Oxprenolol—Betaxolol—CYP2D6—Parkinson's disease	0.000802	0.079	CrCbGaD
Oxprenolol—Bisoprolol—CYP2D6—Parkinson's disease	0.000774	0.0763	CrCbGaD
Oxprenolol—Acebutolol—CYP2D6—Parkinson's disease	0.000733	0.0723	CrCbGaD
Oxprenolol—Alprenolol—CYP2D6—Parkinson's disease	0.000666	0.0656	CrCbGaD
Oxprenolol—Metoprolol—CYP2D6—Parkinson's disease	0.000619	0.061	CrCbGaD
Oxprenolol—Pindolol—CYP2D6—Parkinson's disease	0.000573	0.0565	CrCbGaD
Oxprenolol—Atenolol—ABCB1—Parkinson's disease	0.000567	0.0559	CrCbGaD
Oxprenolol—Acebutolol—ABCB1—Parkinson's disease	0.000524	0.0516	CrCbGaD
Oxprenolol—Propranolol—HTR1A—Parkinson's disease	0.000521	0.0513	CrCbGaD
Oxprenolol—Metoprolol—ABCB1—Parkinson's disease	0.000442	0.0436	CrCbGaD
Oxprenolol—Propranolol—CYP2D6—Parkinson's disease	0.000312	0.0308	CrCbGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000227	0.00176	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000227	0.00175	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000225	0.00174	CbGpPWpGaD
Oxprenolol—Propranolol—ABCB1—Parkinson's disease	0.000223	0.022	CrCbGaD
Oxprenolol—ADRB1—Signaling by GPCR—DGKQ—Parkinson's disease	0.000223	0.00172	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GPR37—Parkinson's disease	0.000223	0.00172	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000222	0.00172	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000222	0.00172	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000222	0.00172	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000222	0.00172	CbGpPWpGaD
Oxprenolol—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000219	0.00169	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000218	0.00168	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GPR37—Parkinson's disease	0.000218	0.00168	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000218	0.00168	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000215	0.00167	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—DLG4—Parkinson's disease	0.000215	0.00166	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000211	0.00163	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—GRIN2B—Parkinson's disease	0.00021	0.00162	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—SLC6A3—Parkinson's disease	0.000207	0.0016	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000204	0.00157	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000202	0.00156	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000199	0.00154	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000198	0.00153	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000195	0.00151	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000195	0.00151	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000191	0.00147	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000191	0.00147	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000186	0.00144	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000182	0.00141	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—COMT—Parkinson's disease	0.000176	0.00136	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000175	0.00136	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—MAOA—Parkinson's disease	0.000175	0.00135	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—TAC1—Parkinson's disease	0.000173	0.00134	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000172	0.00133	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00017	0.00131	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—DRD1—Parkinson's disease	0.000169	0.00131	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	0.000169	0.00131	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GRK5—Parkinson's disease	0.000169	0.0013	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ND3—Parkinson's disease	0.000168	0.0013	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MCCC1—Parkinson's disease	0.000168	0.0013	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000167	0.00129	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	0.000166	0.00128	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	0.000165	0.00128	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—DRD3—Parkinson's disease	0.000164	0.00127	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000163	0.00126	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000161	0.00124	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	0.00016	0.00124	CbGpPWpGaD
Oxprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000159	0.00123	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VPS35—Parkinson's disease	0.000159	0.00123	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000159	0.00123	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PENK—Parkinson's disease	0.000158	0.00122	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TALDO1—Parkinson's disease	0.000158	0.00122	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—OMD—Parkinson's disease	0.000158	0.00122	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000156	0.00121	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000156	0.00121	CbGpPWpGaD
Oxprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000156	0.0012	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	0.000155	0.0012	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	0.000154	0.0012	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000153	0.00118	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GRM4—Parkinson's disease	0.000151	0.00117	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NDUFB11—Parkinson's disease	0.00015	0.00116	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—DRD2—Parkinson's disease	0.000148	0.00115	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HTR7—Parkinson's disease	0.000148	0.00115	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	0.000148	0.00114	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	0.000145	0.00112	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	0.000145	0.00112	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000144	0.00112	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PENK—Parkinson's disease	0.000143	0.00111	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GCH1—Parkinson's disease	0.000143	0.0011	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000141	0.00109	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	0.00014	0.00109	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000136	0.00106	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000134	0.00104	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000133	0.00103	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000133	0.00103	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000133	0.00103	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000132	0.00102	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	0.000131	0.00102	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	0.000131	0.00102	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000131	0.00102	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000131	0.00102	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	0.000131	0.00101	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000131	0.00101	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.000129	0.000995	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.000129	0.000995	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.000128	0.000993	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—FBP1—Parkinson's disease	0.000127	0.000984	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—DBH—Parkinson's disease	0.000127	0.000984	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GBA—Parkinson's disease	0.000127	0.000984	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	0.000122	0.000943	CbGpPWpGaD
Oxprenolol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000122	0.000943	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00012	0.00093	CbGpPWpGaD
Oxprenolol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00012	0.00093	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.000119	0.000923	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	0.000119	0.000919	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000118	0.00091	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.000116	0.000899	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000114	0.000883	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000112	0.000864	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000111	0.00086	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000107	0.000826	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	0.000105	0.000813	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000104	0.000804	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000104	0.000802	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	0.000103	0.000795	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000102	0.000786	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000101	0.000785	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	9.96e-05	0.000771	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	9.91e-05	0.000766	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	9.76e-05	0.000755	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	9.75e-05	0.000754	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	9.69e-05	0.00075	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	9.57e-05	0.00074	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	9.54e-05	0.000738	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	9.36e-05	0.000724	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—DDC—Parkinson's disease	9.34e-05	0.000722	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	9.28e-05	0.000718	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	9.27e-05	0.000717	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	9.07e-05	0.000701	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	9e-05	0.000696	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	8.94e-05	0.000691	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	8.91e-05	0.000689	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	8.86e-05	0.000685	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTA4—Parkinson's disease	8.82e-05	0.000682	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	8.8e-05	0.000681	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	8.74e-05	0.000676	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	8.69e-05	0.000672	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	8.67e-05	0.000671	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.65e-05	0.000669	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	8.64e-05	0.000669	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ND3—Parkinson's disease	8.64e-05	0.000669	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	8.5e-05	0.000658	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	8.47e-05	0.000655	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	8.47e-05	0.000655	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.47e-05	0.000655	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	8.42e-05	0.000651	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	8.38e-05	0.000648	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	8.38e-05	0.000648	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	8.29e-05	0.000641	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	8.29e-05	0.000641	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	8.23e-05	0.000637	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	8.2e-05	0.000634	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	8.2e-05	0.000634	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	8.13e-05	0.000629	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—OMD—Parkinson's disease	8.13e-05	0.000629	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PLA2G6—Parkinson's disease	7.94e-05	0.000614	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MAOB—Parkinson's disease	7.86e-05	0.000608	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	7.86e-05	0.000608	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	7.75e-05	0.000599	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	7.7e-05	0.000596	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	7.69e-05	0.000595	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	7.61e-05	0.000589	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	7.61e-05	0.000589	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	7.58e-05	0.000586	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	7.45e-05	0.000576	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	7.45e-05	0.000576	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GCH1—Parkinson's disease	7.35e-05	0.000568	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	7.29e-05	0.000564	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	7.2e-05	0.000557	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	7.13e-05	0.000551	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	7.05e-05	0.000545	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	6.71e-05	0.000519	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	6.56e-05	0.000508	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GBA—Parkinson's disease	6.55e-05	0.000507	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—FBP1—Parkinson's disease	6.55e-05	0.000507	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—DBH—Parkinson's disease	6.55e-05	0.000507	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	6.32e-05	0.000489	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	6.18e-05	0.000478	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	6.13e-05	0.000474	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	6.09e-05	0.000471	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	5.99e-05	0.000464	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	5.96e-05	0.000461	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	5.87e-05	0.000454	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP2D6—Parkinson's disease	5.84e-05	0.000452	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	5.74e-05	0.000444	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CTGF—Parkinson's disease	5.73e-05	0.000444	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	5.65e-05	0.000437	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	5.53e-05	0.000428	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYP2E1—Parkinson's disease	5.34e-05	0.000413	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	5.34e-05	0.000413	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	5.33e-05	0.000412	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	5.32e-05	0.000411	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NQO1—Parkinson's disease	5.28e-05	0.000409	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	5.23e-05	0.000405	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	5.23e-05	0.000404	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	5.21e-05	0.000403	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TH—Parkinson's disease	5.21e-05	0.000403	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	5.2e-05	0.000402	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	5.13e-05	0.000397	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	5.12e-05	0.000396	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	5.02e-05	0.000388	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CYCS—Parkinson's disease	5e-05	0.000387	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	4.97e-05	0.000385	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	4.86e-05	0.000376	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—DDC—Parkinson's disease	4.81e-05	0.000372	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	4.64e-05	0.000359	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	4.54e-05	0.000351	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.54e-05	0.000351	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	4.5e-05	0.000348	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	4.5e-05	0.000348	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—COMT—Parkinson's disease	4.43e-05	0.000342	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTP1—Parkinson's disease	4.41e-05	0.000341	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	4.4e-05	0.00034	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	4.4e-05	0.00034	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MAOA—Parkinson's disease	4.4e-05	0.00034	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HMOX1—Parkinson's disease	4.35e-05	0.000336	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ABCB1—Parkinson's disease	4.17e-05	0.000323	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	4.09e-05	0.000316	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GSTM1—Parkinson's disease	4.05e-05	0.000313	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MAOB—Parkinson's disease	4.05e-05	0.000313	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GPX1—Parkinson's disease	3.88e-05	0.0003	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	3.77e-05	0.000291	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	3.69e-05	0.000285	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	3.64e-05	0.000282	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	3.6e-05	0.000278	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MTHFR—Parkinson's disease	3.58e-05	0.000277	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	3.56e-05	0.000276	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	3.52e-05	0.000272	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOE—Parkinson's disease	3.33e-05	0.000258	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	3.31e-05	0.000256	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	3.24e-05	0.00025	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	3.15e-05	0.000244	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	3.08e-05	0.000238	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.95e-05	0.000228	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	2.93e-05	0.000226	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	2.86e-05	0.000222	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—INS—Parkinson's disease	2.85e-05	0.00022	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.75e-05	0.000213	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.72e-05	0.00021	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TH—Parkinson's disease	2.68e-05	0.000207	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.57e-05	0.000199	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—INS—Parkinson's disease	2.5e-05	0.000193	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—INS—Parkinson's disease	2.45e-05	0.000189	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—COMT—Parkinson's disease	2.28e-05	0.000176	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.27e-05	0.000175	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.26e-05	0.000175	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.24e-05	0.000173	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2.15e-05	0.000166	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	2.08e-05	0.000161	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GPX1—Parkinson's disease	2e-05	0.000154	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.86e-05	0.000144	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.85e-05	0.000143	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.84e-05	0.000143	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	1.82e-05	0.000141	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	1.81e-05	0.00014	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.72e-05	0.000133	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.71e-05	0.000132	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	1.67e-05	0.00013	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—INS—Parkinson's disease	1.47e-05	0.000113	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	1.09e-05	8.45e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	1.07e-05	8.27e-05	CbGpPWpGaD
